Copolymer 1 in relapsing-remitting multiple sclerosis
Nicholson T, Milne R
Record ID 31998008881
The authors aim to evaluate the efficacy of copolymer 1 in the treatment of relapsing-remitting multiple sclerosis (MS) compared with no treatment in the progression of the disease.
Authors' results and conclusions: Both studies found the copolymer 1 patients had fewer relapses: 119 and 60 respectively in the copolymer 1 group, 168 and 270 in the placebo group.
Authors' recomendations: The authors conclude that copolymer 1 is an expensive drug with small quantifiable benefits in terms of QALYs, and are unconvinced about the merits of introducing it.
Authors' methods: Review
Project Status: Completed
URL for project: http://www.wihrd.soton.ac.uk
Year Published: 1996
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Costs and Cost Analysis
- Immunosuppressive Agents
- Multiple Sclerosis
Organisation Name: Wessex Institute for Health Research and Development
Contact Address: Pauline King. Wessex Institute for Health Research and Development, Boldrewood Medical School, Bassett Crescent East, Highfield, Southampton. SO16 7PX Tel. +44 1703 595661 Fax +44 1703 595662
Copyright: Wessex Institute for Health Research and Development (WIHRD)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.